Back to Authors

Gwinn, Katrina

https://orcid.org/0000-0002-8277-651X

Mayo Clinic

National Institutes of Health

Citations 12

Accurate Determination of Ataxin-2 Polyglutamine Expansion in Patients with Intermediate-Range Repeats
Hussey, Jennifer, Lockhart, Paul J. , Seltzer, William , Hanson, Melissa, Gwinn, Katrina , Farrer, Matthew J. , Wszołek, Zbigniew K. , Payami, Haydeh

Genetic Testing | January 6, 2003 | Volume: 6 | Issue: 3 | Pages: 217-220

10.1089/109065702761403397 Get It

Genetic Classification of Primary Neurodegenerative Disease
Hardy, John , Gwinn, Katrina , Hardy, John

Science | July 27, 2002 | Volume: 282 | Issue: 5391 | Pages: 1075-1079

10.1126/science.282.5391.1075 Get It

During the past 10 years (the “decade of the brain”), some of the genetic causes of many of the primary neurodegenerative diseases, which include Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, prion disease, and many ataxic syndromes, have been found. These breakthroughs mean that for many of these diseases we now know the initiating trigger as well as the final outcome. These diseases have many pathological mechanisms in common, and there may be relatively few pathways to neuronal death seen in these disorders. Thus, treatment strategies developed for a particular disease may be found to have efficacy in more than one disorder.